What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2025-05-15 compared with 2024-11-14 · 33 added, 19 removed, 9 unchanged (85% of the section changed)

Other Information

the fiscal quarter ended September 30, 2024, none of our directors or officers (as defined in Rule 16a-1 under the Exchange Act) adopted

or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” (as those terms are

defined in Item 408 of Regulation S-K).

The information set forth in Part I, Item 2 in the first paragraph under the caption “ Recent Developments

— Management Services Agreement/Payroll Benefits and Expense Reimbursement Agreement with Lucid Diagnostics ” is incorporated

herein by reference.

exhibits filed as part of this Quarterly Report on Form 10-Q are set forth in the “ Exhibit Index ” below.

to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed

on its behalf by the undersigned, thereunto duly authorized.

During the fiscal quarter ended

March 31, 2025, none of our directors or officers (as defined in Rule 16a-1 under the Exchange Act) adopted or terminated a “Rule

10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” (as those terms are defined in Item 408 of Regulation

The exhibits filed as part of this Quarterly Report on

Form 10-Q are set forth in the “ Exhibit Index ” below.

Pursuant to the requirements of

Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the

undersigned, thereunto duly authorized.

/s/ Dennis M McGrath

Dennis M McGrath

and Chief Financial Officer

Financial and Accounting Officer)

Incorporation

Ninth Amendment to Management Services Agreement, dated as of August 6, 2024, by and between PAVmed Inc.

and Lucid Diagnostics Inc.

Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Certification of Principal Financial and Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Certification of Principal Executive Officer pursuant to 18 U.S.C.

Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Certification of Principal Financial and Accounting Officer pursuant to 18 U.S.C.

President and Chief Financial Officer

(Principal Financial and Accounting Officer)

EXHIBIT INDEX

Incorporation by Reference

Certificate of Incorporation

Certificate of Amendment to Certificate of Incorporation

Certificate of Amendment to Certificate of Incorporation, dated October 1, 2018

Certificate of Amendment to Certificate of Incorporation, dated June 26, 2019

Certificate of Amendment to Certificate of Incorporation, dated July 24, 2020

Certificate of Amendment to Certificate of Incorporation, dated June 21, 2022

Certificate of Amendment to Certificate of Incorporation, dated January 15, 2025

Form of Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock

Form of Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock

Pre-Funded Warrants, dated February 21, 2025.

Registration Rights Agreement, dated February 21, 2025.

Certification

of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Certification

of Principal Financial and Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Certification

of Principal Executive Officer pursuant to 18 U.S.C.

Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of

Certification

of Principal Financial and Accounting Officer pursuant to 18 U.S.C.

Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley

XBRL Instance Document

5 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 5. Other Information